Exclusive

Publication

Byline

Location

US Patent Issued to AKSTON BIOSCIENCES on July 21 for "PD-L1 analog fusion proteins for antigen specific immunotherapy and methods of use" (Massachusetts Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,709, issued on July 21, was assigned to AKSTON BIOSCIENCES Corp. (Beverly, Mass.). "PD-L1 analog fusion proteins for antigen specific immun... Read More


US Patent Issued to Bioverativ USA on July 21 for "Methods for treating complement-mediated diseases" (Massachusetts, New Jersey Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,713, issued on July 21, was assigned to Bioverativ USA Inc. (Waltham, Mass.). "Methods for treating complement-mediated diseases" was inven... Read More


US Patent Issued to BIOLOJIC DESIGN on July 21 for "Engineered dual binding antibodies and uses thereof" (Israeli Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,714, issued on July 21, was assigned to BIOLOJIC DESIGN LTD. (Rehovot, Israel). "Engineered dual binding antibodies and uses thereof" was i... Read More


US Patent Issued to Genentech on July 21 for "Methods for treatment of B cell proliferative disorders with anti-CD20/anti-CD3 bispecific antibodies" (California Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,715, issued on July 21, was assigned to Genentech Inc. (South San Francisco, Calif.). "Methods for treatment of B cell proliferative disord... Read More


US Patent Issued to Bristol-Myers Squibb on July 21 for "Cancer immunotherapy by disrupting PD-1/PD-L1 signaling" (Pennsylvania, Maryland, New Jersey, Massachusetts Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,716, issued on July 21, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.). "Cancer immunotherapy by disrupting PD-1/PD-L1 signalin... Read More


US Patent Issued to CENTESSA PHARMACEUTICALS (UK) on July 21 for "Anti-PD-L1 antibodies" (British Inventor)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,717, issued on July 21, was assigned to CENTESSA PHARMACEUTICALS (UK) Ltd. (Altrincham, Great Britain). "Anti-PD-L1 antibodies" was invente... Read More


US Patent Issued on July 21 for "Targeted binding agents against B7-H1" (American, Canadian, British Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,718, issued on July 21. "Targeted binding agents against B7-H1" was invented by Christophe Queva (Bainbridge Island, Wash.), Michelle Morro... Read More


US Patent Issued to University of Cincinnati, Children's Hospital Medical Center, Christian-Albrechts-Universitat Zu Kiel on July 21 for "Suppressing IgE-mediated allergy by desensitization with monovalent anti-FCeRIa monoclonal antibody" (American, Israeli, German Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,719, issued on July 21, was assigned to University of Cincinnati (Cincinnati), Children's Hospital Medical Center (Cincinnati) and Christian... Read More


US Patent Issued to DIAGONAL THERAPEUTICS on July 21 for "Bispecific agonistic antibodies to activin a receptor like type 1 (ALK1)" (Massachusetts Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,720, issued on July 21, was assigned to DIAGONAL THERAPEUTICS INC. (Watertown, Mass.). "Bispecific agonistic antibodies to activin a recept... Read More


US Patent Issued to INTERVET on July 21 for "Bispecific caninized antibodies and bispecific binding partners for treating atopic dermatitis" (Nebraska, New Jersey, California Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,721, issued on July 21, was assigned to INTERVET INC. (Rahway, N.J.). "Bispecific caninized antibodies and bispecific binding partners for ... Read More